Year: 2020

news_6

LianBio Announces Clearance to Initiate the Phase 3 PROOF Trial of Infigratinib in Patients with Locally Advanced or Metastatic Unresectable Cholangiocarcinoma with FGFR2 Gene Fusions in China

SHANGHAI & PRINCETON, N.J.--(BUSINESS WIRE)--LianBio, a biotechnology company focused on bringing paradigm-shifting medicines to patients in China and major Asian...

news_6

Insights into the Energy and Utility Analytics Global Market to 2027 – Featuring ABB, BuildingIQ & Capgemini Among Others – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Energy and Utility Analytics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The...

news_6

Transportable Liver Perfusion System Market Insights (2020 to 2025) – Analysis and Forecast for the Global and Chinese Markets – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Transportable Liver Perfusion System Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers,...

news_6

Electrical Equipment Market in India 2020-2024: Business Overview, Industry Size and Share, Opportunities, Impact of Drivers, Key Vendors, Products, Applications

LONDON--(BUSINESS WIRE)--#ElectricalEquipmentMarketinIndia--The electrical equipment market research in India from Technavio indicates Negative growth in the short term as the business...

news_6

Humanigen Executes Licensing Agreement for Lenzilumab™ in COVID-19 with KPM Tech/Telcon RF Pharmaceutical for South Korea and the Philippines

Agreement provides Humanigen up to US$20 million in milestones and double-digit royalties on product sales Transaction supports the Humanigen Asia-Pacific...